The Vicore COMPANION study seeks volunteers to test a software-based treatment for the symptoms of anxiety and depression in those diagnosed with Idiopathic Pulminary Fibrosis (IPF).

At home
study

Four
Weeks

Compensation
of $100

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Who can participate in this study?

You may be eligible if you meet both criteria.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

1.

You have been diagnosed with Idiopathic Pulmonary Fibrosis (IPF)

2.

You have some level of anxiety

How might at-home digital therapy help treat my anxiety and depression related to IPF?

Cognitive behavioral therapy (CBT) is a recommended first-line treatment for anxiety.  This digital therapy is available on any cell phone or tablet. In this study you will receive access to this treatment and provide your feedback on your experience with it over the next 4 weeks.

Click below to see if you are eligible.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

How can I participate?

STEP

01

Take a short survey here to check if you qualify for the study

STEP

02

If you qualify, you’ll be immediately taken to a confirmation page to upload your diagnosis confirmation and sign a records release form to confirm your IPF diagnosis

STEP

03

After we confirm your diagnosis you’ll be able to schedule a video call with a member of our research team to finalize your enrollment and get set up to participate in the study

STEP

04

Participate in 10 minute daily sessions in the digital therapeutic app over the course of 4 weeks while taking part in questionaires and video interviews

What is this study about?

Receiving a diagnosis of idiopathic pulmonary fibrosis (IPF) is typically coupled with dyspnea, fatigue, and cough symptoms that usually worsen. The impact of living with IPF can have negative effect on mental health.

Frequently Asked Questions

Who can participate?
This study will evaluate if cognitive behavioral therapy used on smartphone or tablet device can reduce anxiety and depression and increase wellbeing in patients with IPF.
What will happen in this study?
If you decide to join this study, the study team will check if you are eligible for participation. They will check if you have an IPF diagnosis and will also check if you fulfill the other criteria for participation in the trial. They will ask questions about the medicine you are using and if you have other diseases. During participation you must use the digital therapy via an App downloaded to your smartphone or tablet device for approximately 10 minutes per day. There will also be exercises suggested to you. You will be asked to complete questionnaires and 2 video interviews will take place via Curebase. Curebase is a US company running the study on behalf of Vicore.
What are the possible benefits of taking part?
By participating in this study, you will receive free access to a digital therapy. By using the digital therapy, you may experience a reduction in your anxiety and depression. Information learned from the study may help people with IPF managing their anxiety and depression in the future.
Who is organizing and funding the research?
Vicore pharma is a Swedish biotech company focused on therapies for patients with severe lung diseases.